Searched for
ASTRA DEAL
Doubled in 5 years: India's military-industrial moment has arrivedIndia's defence production has surged to a record Rs 1.78 lakh crore in FY26, nearly quadrupling since 2013-14. This growth, fueled by the ...- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Corporate India gets a call of duty and it's raring to goIn a dynamic shift, India's defence industry is witnessing a groundbreaking transformation where private corporations are spearheading pivo...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- Trump administration readies new tariffs on select drugmakers: ReportThe Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...
- Banquets and billions: How AstraZeneca sealed a US medicine deal with TrumpAstraZeneca CEO Pascal Soriot met with U.S. President Donald Trump to finalize a medicine deal. This agreement will lower drug prices for m...
- AstraZeneca signs AI research deal with China's CSPC for chronic diseasesUnder Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule or...
- AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolioAstraZeneca announced its acquisition of Amolyt Pharma, a company focused on endocrine diseases, for $1.05 billion in cash. This move aims ...
- AstraZeneca, AI biologics firm Absci tie up on cancer drugAbsci's collaboration with AstraZeneca aims for a zero-shot generative AI model designed to create new and improved antibody therapeutics
- EU seeks new COVID-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU- SourcesThe European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the do...
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
- AstraZeneca sells cholesterol drug rights to Grünenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
- AstraZeneca in first COVID-19 vaccine deal with Chinese companyThe deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...
- AstraZeneca gets extension for Meronem withdrawal till August 31The product is currently one of the company's principal products which generated 18 per cent total turnover of the firm in fiscal ended Mar...
- Pfizer has not discussed AstraZeneca bid with regulators: European Union's AlmuniaPfizer is seeking to acquire Britain's second-biggest drugmaker and may have to sweeten its offer after AstraZeneca rejected the bid.
- HCL Technologies replaces IBM as IT infra vendor of AstraZenecaHCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.
- Pfizer, Astra deals to drive Aurobindo Pharma’s growthA ramp-up in its deal with Pfizer resulted in a decent growth in its US and Europe sales. The net profit also got a boost from a forex gain...
- Infy bags multi-million Astra dealInfosys Technologies has won a five-year, multi-million dollar global sourcing deal from pharma giant AstraZeneca.
Load More
